A Randomized, Prospective, Placebo-Controlled Clinical Trial of a Novel Zinc-Monocysteine Compound in Age-Related Macular Degeneration

Author： Newsome David  

Publisher： Informa Healthcare

ISSN： 0271-3683

Source： Current Eye Research, Vol.33, Iss.7, 2008-07, pp. : 591-598

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dexamethasone Intravitreal Implant as Adjunctive Therapy to Ranibizumab in Neovascular Age-Related Macular Degeneration: A Multicenter Randomized Controlled Trial

By  

Ophthalmologica, Vol. 234, Iss. 1, 2015-06 ,pp. : 40-54

Karger

Access to resources Recommend Favorite

Role of Lutein Supplementation in the Management of Age-Related Macular Degeneration: Meta-Analysis of Randomized Controlled Trials

By  

Ophthalmic Research, Vol. 52, Iss. 4, 2014-10 ,pp. : 198-205

Karger

Access to resources Recommend Favorite

A Review of Ranibizumab Clinical Trial Data in Exudative Age-Related Macular Degeneration and How to Translate It into Daily Practice

By  

Ophthalmologica, Vol. 225, Iss. 2, 2010-10 ,pp. : 112-119

Karger

Access to resources Recommend Favorite

Prospective, Randomized Intervention Study Comparing Retinal Pigment Epithelium-Choroid Graft Surgery and Anti-VEGF Therapy in Patients with Exudative Age-Related Macular Degeneration

By  

Ophthalmologica, Vol. 233, Iss. 3-4, 2015-03 ,pp. : 134-145

Karger

Access to resources Recommend Favorite

Micronutrients in Age-Related Macular Degeneration

By  

Ophthalmologica, Vol. 229, Iss. 2, 2012-11 ,pp. : 75-79

Karger

Access to resources Recommend Favorite